CA2294651A1 - Surface exposed proteins from chlamydia pneumoniae - Google Patents
Surface exposed proteins from chlamydia pneumoniae Download PDFInfo
- Publication number
- CA2294651A1 CA2294651A1 CA002294651A CA2294651A CA2294651A1 CA 2294651 A1 CA2294651 A1 CA 2294651A1 CA 002294651 A CA002294651 A CA 002294651A CA 2294651 A CA2294651 A CA 2294651A CA 2294651 A1 CA2294651 A1 CA 2294651A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- ser
- gly
- thr
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/125—Gram-negative bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK74497 | 1997-06-23 | ||
| DK0744/97 | 1997-06-23 | ||
| PCT/DK1998/000266 WO1998058953A2 (en) | 1997-06-23 | 1998-06-19 | Surface exposed proteins from chlamydia pneumoniae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2294651A1 true CA2294651A1 (en) | 1998-12-30 |
Family
ID=8097044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002294651A Abandoned CA2294651A1 (en) | 1997-06-23 | 1998-06-19 | Surface exposed proteins from chlamydia pneumoniae |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7264941B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1007685B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4160640B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN1249233C (cg-RX-API-DMAC10.html) |
| AT (1) | ATE323164T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU749382B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9810288A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2294651A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE69834194T2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK1007685T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2264810T3 (cg-RX-API-DMAC10.html) |
| PT (1) | PT1007685E (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998058953A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
| US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
| US6649370B1 (en) * | 1998-10-28 | 2003-11-18 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| EP1129202A2 (en) * | 1998-10-28 | 2001-09-05 | Aventis Pasteur Limited | Chlamydia antigenes and corresponding dna fragments and uses thereof |
| US6872814B2 (en) * | 1998-10-29 | 2005-03-29 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| NZ512308A (en) * | 1998-12-01 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| AU3790900A (en) | 1998-12-01 | 2000-06-19 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| EP2172214A3 (en) | 1999-03-12 | 2011-03-16 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| WO2000066739A2 (en) * | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| CA2385325C (en) * | 1999-09-20 | 2012-04-10 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| US20010048927A1 (en) | 2000-02-01 | 2001-12-06 | Richard Stephens | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| ATE440861T1 (de) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US7105171B2 (en) | 2002-03-07 | 2006-09-12 | The Regents Of The University Of California | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| EP3452197A4 (en) | 2016-05-04 | 2020-01-22 | Children's Hospital & Research Center at Oakland | FAST EXTRACTION OF NUCLEIC ACIDS FROM CLINICAL SAMPLES FOR DOWNSTREAM APPLICATIONS |
| US20220221456A1 (en) * | 2019-05-06 | 2022-07-14 | Arocell Ab | Respiratory infection detection and classification |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU692889B2 (en) * | 1994-08-03 | 1998-06-18 | Hitachi Chemical Company, Ltd. | Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection |
| CN100365017C (zh) | 1994-09-20 | 2008-01-30 | 日立化成工业株式会社 | 肺炎衣原体抗原多肽 |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
-
1998
- 1998-06-19 ES ES98928179T patent/ES2264810T3/es not_active Expired - Lifetime
- 1998-06-19 DE DE69834194T patent/DE69834194T2/de not_active Expired - Lifetime
- 1998-06-19 JP JP50361399A patent/JP4160640B2/ja not_active Expired - Fee Related
- 1998-06-19 AT AT98928179T patent/ATE323164T1/de not_active IP Right Cessation
- 1998-06-19 DK DK98928179T patent/DK1007685T3/da active
- 1998-06-19 AU AU80119/98A patent/AU749382B2/en not_active Ceased
- 1998-06-19 US US09/446,677 patent/US7264941B1/en not_active Expired - Fee Related
- 1998-06-19 WO PCT/DK1998/000266 patent/WO1998058953A2/en not_active Ceased
- 1998-06-19 PT PT98928179T patent/PT1007685E/pt unknown
- 1998-06-19 CA CA002294651A patent/CA2294651A1/en not_active Abandoned
- 1998-06-19 EP EP98928179A patent/EP1007685B1/en not_active Expired - Lifetime
- 1998-06-19 BR BR9810288-5A patent/BR9810288A/pt not_active Application Discontinuation
- 1998-06-19 CN CNB988064286A patent/CN1249233C/zh not_active Expired - Fee Related
-
2007
- 2007-07-12 US US11/826,125 patent/US20080226679A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE323164T1 (de) | 2006-04-15 |
| US20080226679A1 (en) | 2008-09-18 |
| JP2002510970A (ja) | 2002-04-09 |
| EP1007685A2 (en) | 2000-06-14 |
| ES2264810T3 (es) | 2007-01-16 |
| WO1998058953A2 (en) | 1998-12-30 |
| AU749382B2 (en) | 2002-06-27 |
| PT1007685E (pt) | 2006-08-31 |
| AU8011998A (en) | 1999-01-04 |
| DK1007685T3 (da) | 2006-08-14 |
| WO1998058953A3 (en) | 1999-03-18 |
| US7264941B1 (en) | 2007-09-04 |
| DE69834194D1 (de) | 2006-05-24 |
| CN1249233C (zh) | 2006-04-05 |
| DE69834194T2 (de) | 2007-03-29 |
| BR9810288A (pt) | 2000-09-19 |
| CN1261403A (zh) | 2000-07-26 |
| EP1007685B1 (en) | 2006-04-12 |
| JP4160640B2 (ja) | 2008-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080226679A1 (en) | Novel surface exposed proteins from chlamydia pneumoniae | |
| Luo et al. | Cloning and characterization of the major outer membrane protein gene (ompH) of Pasteurella multocida X-73 | |
| EA015561B1 (ru) | НОВЫЙ ПОВЕРХНОСТНЫЙ БЕЛОК HAEMOPHILUS INFLUENZAE (БЕЛОК E; pE) | |
| JP3440221B2 (ja) | アクチノバチルス・プレウロニウモニアからのタンパク質 | |
| US10463727B2 (en) | Targets of acinetobacter baumannii | |
| RU2252224C2 (ru) | Пептид со свойствами антигена neisseria meningitidis, кодирующий его полинуклеотид, вакцина для лечения или предотвращения заболеваний или состояний, вызванных neisseria meningitidis, (варианты), антитело, связывающееся с указанным пептидом | |
| CA2366520A1 (en) | Anti-bacterial vaccine compositions | |
| NZ309945A (en) | Abundant extracellular products and their use as vaccines | |
| CA2719041C (en) | A method for identifying polypeptides which comprise a cross-reactive antigenic determinant | |
| CA2326002A1 (en) | Chlamydia proteins and their uses | |
| EP1005365B1 (en) | Epitopes of an extracellular antigen | |
| US7300660B2 (en) | Abundant extracellular products and methods for their production and use | |
| US7449302B2 (en) | Therapeutic peptides | |
| AU2535699A (en) | Method for detecting intimin producing microorganisms | |
| WO1997003359A1 (en) | Helicobacter clpb | |
| KR20080052693A (ko) | 유전자, 단백질 및 그들의 용도 | |
| EP2277534A1 (en) | Immunogenic and therapeutic compositions for streptococcus suis | |
| CA2253834A1 (en) | B. burgdorferi polypeptides expressed in vivo | |
| JP2002541766A (ja) | クラミジア抗原および対応するdna断片ならびにその使用 | |
| WO2000062069A1 (en) | Method of detecting intimin-expressing microorganisms | |
| CA2440874A1 (en) | Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof | |
| HK1149770B (en) | Compositions, methods and kits | |
| CZ148399A3 (cs) | Sekvence nukleových kyselin a aminokyselin Helicobacter pylori a vakcinační prostředky |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |